The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy (exagamglogene autotemcel) for ...
The new platform enables traders to compare prop firms side by side using hundreds of funding rules, account features and trading conditions, making it one of the most comprehensive futures prop firm ...
Wedbush today announced that Dan Ives, MD, Global Head of Technology Research, has departed the firm to establish a new investment banking venture. “Dan has been an exceptional team member of Wedbush, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results